Published in Lancet on November 03, 1973
The problem and implications of chloramphenicol resistance in the typhoid bacillus. J Hyg (Lond) (1975) 3.30
Epidemiology, Clinical Presentation, Laboratory Diagnosis, Antimicrobial Resistance, and Antimicrobial Management of Invasive Salmonella Infections. Clin Microbiol Rev (2015) 1.48
Use of temocillin in typhoid fever, hepatobiliary disease and other infections. Drugs (1985) 1.47
Two or three days of ofloxacin treatment for uncomplicated multidrug-resistant typhoid fever in children. Antimicrob Agents Chemother (1996) 1.33
Does chloramphenicol remain the drug of choice for typhoid? Epidemiol Infect (1987) 1.31
A plasmid in Legionella pneumophila. Infect Immun (1980) 1.26
In vitro susceptibility of Salmonella to various antimicrobial agents, including a new cephalosporin, Ro 13-9904. Antimicrob Agents Chemother (1981) 1.23
Cefazolin in the treatment of acute enteric fever. Antimicrob Agents Chemother (1976) 1.22
Inhibition of bacteriophage lambda, T1, and T7 development by R plasmids of the H incompatibility group. Antimicrob Agents Chemother (1976) 1.13
Therapy of antimicrobial-resistant typhoid fever. Antimicrob Agents Chemother (1977) 1.09
The effect on the virulence and infectivity of Salmonella typhimurium and Salmonella gallinarum of acquiring antibiotic resistance plasmids from organisms that had caused serious outbreaks of disease. J Hyg (Lond) (1979) 1.04
Oxolinic acid in the treatment of typhoid fever due to chloramphenicol-resistant strains of Salmonella typhi. Antimicrob Agents Chemother (1976) 0.97
Drug resistance and R plasmids in Salmonella typhi isolated in Korea. Antimicrob Agents Chemother (1977) 0.96
Lactose-fermenting, multiple drug-resistant Salmonella typhi strains isolated from a patient with postoperative typhoid fever. J Clin Microbiol (1983) 0.96
In vivo selection for transmissible drug resistance in Salmonella typhi during antimicrobial therapy. Antimicrob Agents Chemother (1990) 0.95
Effect of a Salmonella group H1 R factor on virulence and response of infections to antimicrobial therapy. Antimicrob Agents Chemother (1979) 0.92
The geographical distribution of Salmonella typhi and Salmonella paratyphi A and B phage types during the period 1 January 1970 to 31 December 1973. A report of the International Federation for Enteric Phage-Typing (IFEPT). J Hyg (Lond) (1982) 0.80
Comparative in vitro activity of five cephalosporin antibiotics against salmonellae. Antimicrob Agents Chemother (1978) 0.80
Jeremiah Metzger lecture: Salmonella infections--newer perspectives of an old infection. Trans Am Clin Climatol Assoc (1974) 0.75
Ofloxacin, a new quinolone in the treatment of genitourinary and enteric infections. Infection (1986) 0.75
Complex promoter and coding region beta 2-adrenergic receptor haplotypes alter receptor expression and predict in vivo responsiveness. Proc Natl Acad Sci U S A (2000) 10.27
Haplotype variation and linkage disequilibrium in 313 human genes. Science (2001) 8.52
Needle fixation, the drug user's perspective: a qualitative study. Addiction (2001) 4.41
Distribution of thiols in microorganisms: mycothiol is a major thiol in most actinomycetes. J Bacteriol (1996) 3.98
Unidentified gram-negative rod infection. A new disease of man. Ann Intern Med (1977) 3.53
Passive protection by antitoxin in experimental Pseudomonas aeruginosa burn infections. Infect Immun (1977) 3.25
Neutralizing antibody to Pseudomonas aeruginosa exotoxin in human sera: evidence for in vivo toxin production during infection. Infect Immun (1976) 2.69
Protective activity of antibodies to exotoxin A and lipopolysaccharide at the onset of Pseudomonas aeruginosa septicemia in man. J Clin Invest (1979) 2.50
Exotoxin production by clinical isolates of pseudomonas aeruginosa. Infect Immun (1977) 2.38
Urodynamic variables cannot be used to classify the severity of detrusor instability. Br J Urol (1998) 2.36
A MEASURE-THEORETIC COMPUTATIONAL METHOD FOR INVERSE SENSITIVITY PROBLEMS I: METHOD AND ANALYSIS. SIAM J Numer Anal (2011) 2.27
The rate of decline of diphenylhydantoin in human plasma. Clin Pharmacol Ther (1970) 2.23
Prolactin-dependent rat mammary cancer: a model for man? Trans Assoc Am Physicians (1969) 2.15
Randomised trial of artesunate and mefloquine alone and in sequence for acute uncomplicated falciparum malaria. Lancet (1992) 2.14
Influence of docosahexaenoic acid and cholesterol on lateral lipid organization in phospholipid mixtures. Biochemistry (1998) 2.12
Neisseria gonorrhoeae strains isolated in Hong Kong: in vitro susceptibility to 13 antibiotics. Antimicrob Agents Chemother (1981) 1.98
Effect of antibiotic class and concentration on the release of lipopolysaccharide from Escherichia coli. J Infect Dis (1993) 1.98
Penicillinase-producing Neisseria gonorrhoeae isolates from different localities in south east Asia. Susceptibility to 15 antibiotics. Br J Vener Dis (1983) 1.96
Electrocardiographic manifestations: digitalis toxicity. J Emerg Med (2001) 1.93
Lenercept (p55 tumor necrosis factor receptor fusion protein) in severe sepsis and early septic shock: a randomized, double-blind, placebo-controlled, multicenter phase III trial with 1,342 patients. Crit Care Med (2001) 1.88
Antimalarial activity of mefloquine and qinghaosu. Lancet (1982) 1.81
Cholera in Piura, Peru: a modern urban epidemic. J Infect Dis (1992) 1.80
Water permeability of polyunsaturated lipid membranes measured by 17O NMR. Biophys J (1997) 1.79
Mortality among homeless people with schizophrenia in Sydney, Australia: a 10-year follow-up. Acta Psychiatr Scand (2001) 1.68
Mechanism of action of Pseudomonas aeruginosa exotoxin A in experimental mouse infections: adenosine diphosphate ribosylation of elongation factor 2. Infect Immun (1978) 1.66
Identification of the low density lipoprotein receptor-binding site in apolipoprotein B100 and the modulation of its binding activity by the carboxyl terminus in familial defective apo-B100. J Clin Invest (1998) 1.59
Risk factors for development of hemolytic uremic syndrome during shigellosis. J Pediatr (1987) 1.53
Factors influencing colonisation and antibiotic-resistance patterns of gram-negative bacteria in hospital patients. Lancet (1972) 1.52
Typhoid fever. Studies of blood coagulation, bacteremia, and endotoxemia. Arch Intern Med (1978) 1.52
Serum antibody to Pseudomonas aeruginosa exotoxin measured by a passive hemagglutination assay. J Clin Microbiol (1977) 1.52
Shigella septicemia: prevalence, presentation, risk factors, and outcome. J Infect Dis (1985) 1.52
Should the administration of ECT during clozapine therapy be contraindicated? Br J Psychiatry (1996) 1.47
Cytokine gene transcription by NF-kappa B family members in patients with inflammatory bowel disease. Ann N Y Acad Sci (1998) 1.46
Role of meningococcal endotoxin in meningococcal purpura. J Exp Med (1974) 1.45
Septicemia caused by Capnocytophaga in a granulocytopenic patient with glossitis. Arch Intern Med (1980) 1.44
Typhoid fever complicated by intestinal perforation: a persisting fatal disease requiring surgical management. Rev Infect Dis (1985) 1.44
Comparison of artemisinin suppositories with intravenous artesunate and intravenous quinine in the treatment of cerebral malaria. Trans R Soc Trop Med Hyg (1993) 1.43
Randomised comparative study of mefloquine, qinghaosu, and pyrimethamine-sulfadoxine in patients with falciparum malaria. Lancet (1984) 1.42
Sounding the improvement in outcomes in pediatric critical care: are we listening for only what we want to hear? Crit Care Med (1998) 1.42
Educational program for physicians to reduce use of non-steroidal anti-inflammatory drugs among community-dwelling elderly persons: a randomized controlled trial. Med Care (2001) 1.41
Assessment of the safety of recombinant tissue factor pathway inhibitor in patients with severe sepsis: a multicenter, randomized, placebo-controlled, single-blind, dose escalation study. Crit Care Med (2001) 1.41
Amphotericin B induces tumor necrosis factor production by murine macrophages. J Infect Dis (1989) 1.40
The acidosis of cholera. Contributions of hyperproteinemia, lactic acidemia, and hyperphosphatemia to an increased serum anion gap. N Engl J Med (1986) 1.40
Chitinases in trypanosomatidae: a cautionary note. Parasitol Today (1992) 1.39
Toxicity of Pseudomonas aeruginosa exotoxin A for human macrophages. Infect Immun (1978) 1.38
Isolation of Intact Chloroplasts from Euglena gracilis by Zonal Centrifugation. Plant Physiol (1971) 1.38
Detection of individual phospholipids in lipid mixtures by matrix-assisted laser desorption/ionization time-of-flight mass spectrometry: phosphatidylcholine prevents the detection of further species. Anal Biochem (2001) 1.36
Liquefaction of Autographa californica nucleopolyhedrovirus-infected insects is dependent on the integrity of virus-encoded chitinase and cathepsin genes. Virology (1997) 1.34
Matrix-assisted laser desorption and ionization time-of-flight (MALDI-TOF) mass spectrometry in lipid and phospholipid research. Prog Lipid Res (2004) 1.34
Activation of protein mediators of inflammation and evidence for endotoxemia in Borrelia recurrentis infection. Am J Med (1977) 1.34
Azithromycin versus ciprofloxacin for treatment of uncomplicated typhoid fever in a randomized trial in Egypt that included patients with multidrug resistance. Antimicrob Agents Chemother (1999) 1.33
The global atmospheric environment for the next generation. Environ Sci Technol (2006) 1.30
Purification of Pseudomonas aeruginosa exotoxin by affinity chromatography. Infect Immun (1978) 1.28
Enhanced survival in Pseudomonas aeruginosa septicemia associated with high levels of circulating antibody to Escherichia coli endotoxin core. J Clin Invest (1983) 1.28
MMX Multi Matrix System mesalazine for the induction of remission in patients with mild-to-moderate ulcerative colitis: a combined analysis of two randomized, double-blind, placebo-controlled trials. Aliment Pharmacol Ther (2007) 1.28
Possible medication errors in home healthcare patients. J Am Geriatr Soc (2001) 1.27
Yersinia pestis infection in Vietnam. II. Quantiative blood cultures and detection of endotoxin in the cerebrospinal fluid of patients with meningitis. J Infect Dis (1976) 1.26
The virulence of Pseudomonas aeruginosa. Rev Infect Dis (1987) 1.26
The use of oral replacement solutions in the treatment of choleraand other severe diarrhoeal disorders. Bull World Health Organ (1970) 1.25
Electrocardiographic manifestations: pulmonary embolism. J Emerg Med (2001) 1.25
Randomized treatment of patients with typhoid fever by using ceftriaxone or chloramphenicol. J Infect Dis (1988) 1.24
Botulism in an adult associated with food-borne intestinal infection with Clostridium botulinum. N Engl J Med (1986) 1.24
The dielectric properties of aqueous solutions of poly(ethylene glycol) and their influence on membrane structure. Biochim Biophys Acta (1985) 1.23
Functionally active monoclonal antibody that recognizes an epitope on the O side chain of Pseudomonas aeruginosa immunotype-1 lipopolysaccharide. Infect Immun (1986) 1.23
In vitro susceptibility of Salmonella to various antimicrobial agents, including a new cephalosporin, Ro 13-9904. Antimicrob Agents Chemother (1981) 1.23
Lipid analysis of human HDL and LDL by MALDI-TOF mass spectrometry and (31)P-NMR. J Lipid Res (2001) 1.22
Lipid analysis by matrix-assisted laser desorption and ionization mass spectrometry: A methodological approach. Anal Biochem (1999) 1.21
In vitro susceptibility of Haemophilus influenzae and neisseria gonorrhoeae to Ro 13-9904 in comparison with other beta-lactam antibiotics. Antimicrob Agents Chemother (1981) 1.21
Evaluation of sputum smear microscopy in the National Tuberculosis Control Programme in the north of Vietnam. Int J Tuberc Lung Dis (2006) 1.20
Dynamics of membrane penetration of the fluorescent 7-nitrobenz-2-oxa-1,3-diazol-4-yl (NBD) group attached to an acyl chain of phosphatidylcholine. Biophys J (2001) 1.19
Oral health status of prison inmates--New South Wales, Australia. Aust Dent J (2003) 1.16
Severe and complicated malaria treated with artemisinin, artesunate or artemether in Viet Nam. Trans R Soc Trop Med Hyg (1997) 1.16
Randomized controlled trial of berberine sulfate therapy for diarrhea due to enterotoxigenic Escherichia coli and Vibrio cholerae. J Infect Dis (1987) 1.15
A neurological basis for visual discomfort. Brain (1984) 1.15
Assignment of autosomal dominant spinocerebellar ataxia (SCA1) centromeric to the HLA region on the short arm of chromosome 6, using multilocus linkage analysis. Am J Hum Genet (1989) 1.14
Journal to encourage analysis by sex/ethnicity. J Natl Cancer Inst (2000) 1.14
The use of solid-phase radioimmunoassay techniques for serodiagnosis of human plague infection. Bull Pan Am Health Organ (1980) 1.13
Acute lower respiratory tract infection due to virus among hospitalized children in Dhaka, Bangladesh. Rev Infect Dis (1991) 1.13
A prospective double-blind study of side effects associated with the administration of amantadine for influenza A virus prophylaxis. J Infect Dis (1980) 1.13
Antibacterial and protective properties of monoclonal antibodies reactive with Escherichia coli O111:B4 lipopolysaccharide: relation to antibody isotype and complement-fixing activity. J Infect Dis (1992) 1.12
Antibody activity against Pseudomonas aeruginosa in immune globulins prepared for intravenous use in humans. J Infect Dis (1983) 1.12
Individual traits and family contexts predict sons' externalizing behavior and preliminary relative risk ratios for conduct disorder and substance use disorder outcomes. Drug Alcohol Depend (1999) 1.11
Pseudomonas aeruginosa exotoxin A. N Engl J Med (1980) 1.11
1H and 13C HR-MAS NMR investigations on native and enzymatically digested bovine nasal cartilage. MAGMA (2001) 1.10
Experimental hypercholesterolemia induces apoptosis in the aortic valve. J Heart Valve Dis (2001) 1.10
Identification of the major site of apolipoprotein B modification by advanced glycosylation end products blocking uptake by the low density lipoprotein receptor. J Biol Chem (1995) 1.10
Surface dielectric constant, surface hydrophobicity and membrane fusion. J Membr Biol (1990) 1.10
Therapy of antimicrobial-resistant typhoid fever. Antimicrob Agents Chemother (1977) 1.09
The role of exotoxin A in pseudomonas disease and immunity. Rev Infect Dis (1984) 1.08
Powder and mechanical properties of microcrystalline cellulose with different degrees of polymerization. AAPS PharmSciTech (2002) 1.08
Comparative efficacies of pivmecillinam and ampicillin in acute shigellosis. Antimicrob Agents Chemother (1984) 1.08